Eli Lilly reveals plans to invest $1.8 billion in Ireland to grow its manufacturing business

This investment will increase the output of biologic active substances, especially for obesity and Alzheimer's disease therapies.

The funds will go towards two significant projects in Ireland for expansion. A $1 billion expansion at Lilly's Limerick plant is the first of these.

As a result of this development, the company's original investment, which was disclosed in March 2023, will be doubled, totalling a significant $2 billion.

When finished, the Limerick plant will play a key role in Lilly's worldwide manufacturing network, providing biologic active ingredients for other biologic medications as well as the recently authorised therapy for Alzheimer's disease.

To ensure accurate and effective production processes, the expansion will include cutting-edge technology including autonomous robots, artificial intelligence, and machine learning.

Additionally, it will create 150 new highly skilled positions, bringing Limerick's workforce to 450 by the time production starts in 2026.

The Limerick City and County Council will receive a formal application for the project, which is presently pending planning permission.

Eli Lilly is spending $800 million to upgrade its Kinsale factory, which started up last year, at the same time.

(Sources: investing.com, reuters.com)